What is the place of a profit motive in the production of knowledge at public universities?

Quick Read

Drugmakers are racing to scoop up patient health records and strike deals with technology companies as big data analytics start to unlock a trove of information about how medicines perform in the real world

Quick Read

Amazon, Berkshire Hathaway and JPMorgan Chase announced on Tuesday that they would form an independent health care company to serve their employees in the United States

Quick Read

When one of Martha Jane Pierce’s sons peeled back the white sock that had been covering his 82-year-old mother’s right foot for a month, he discovered rotting flesh

Quick Read

Around the world, human-rights activists fight on behalf of people imprisoned in unsanitary jails and denied a fair trial. These victims often suffer the double indignity of being mistreated by their captors and deprived of basic services. In many countries, these abuses are not only taking places in prisons, but in hospitals, too

Quick Read

This week, pharmaceutical giant CVS announced it was preparing to buy the insurance company Aetna for $69 billion. The merger could have a profound impact on the way Americans receive healthcare — and it also raises a number of privacy concerns, said medical ethicist Arthur Caplan

Quick Read

How to Protect a Drug Patent?

September 11, 2017

Sell it to a Native American Tribe. The drugmaker Allergan announced Friday that it had transferred its patents on a best-selling eye drug to the Saint Regis Mohawk Tribe in upstate New York — an unusual gambit to protect the drug from a patent dispute

Quick Read

In April, Gundy’s child, who is on private insurance, began getting the drug Spinraza, which costs $750,000 for the initial year of treatment. Chaffin’s child — a Medicaid enrollee — was not receiving the drug, as his state regulators debated whether to offer it to children like him who use ventilators to breathe

Quick Read